Page last updated: 2024-08-22

angiotensin ii and Hyperlipemia

angiotensin ii has been researched along with Hyperlipemia in 39 studies

Research

Studies (39)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (10.26)	18.7374
1990's	4 (10.26)	18.2507
2000's	21 (53.85)	29.6817
2010's	5 (12.82)	24.3611
2020's	5 (12.82)	2.80

Authors

Authors	Studies
Chao de la Barca, JM; Eid, M; Fassot, C; Faure, J; Fouquet, O; Henrion, D; Loufrani, L; Reynier, P; Richard, A; Robert, P; Tessier, L; Wetterwald, C	1
Ge, J; Ma, J; Ma, L; Ma, Y; Wu, R; Zou, Y	1
Chen, L; FitzGerald, GA; Jiang, T; Monslow, J; Puré, E; Tang, SY; Todd, L; Yang, G; Zhang, J	1
Autieri, MV; Corbett, CB; Okune, R; St Paul, A	1
Grochot-Przęczek, A; Hajduk, K; Józkowicz, A; Klóska, D; Kopacz, A; Piechota-Polańczyk, A; Werner, E	1
Cassis, LA; Thatcher, SE; Wang, Y	1
Berliner, JA; Cai, L; Graham, MJ; Kim, S; Lee, RG; Lee, S; Lusis, AJ; Rateri, DL; Temel, RE; Yang, L	1
Guo, J; Huo, ZJ; Ji, XL; Li, FY; Liu, C; Peng, B; Shen, HB; Zhang, L	1
Weintraub, NL	1
Chan, EC; Dilley, R; Dusting, GJ; Guo, N; Jiang, F; Narumiya, S; Peshavariya, HM; Taylor, CJ	1
Fukuda, D; Libby, P; Rocha, VZ; Shi, GP; Shimizu, K; Shvartz, E; Sukhova, G; Tang, EH; Zheng, C	1
Gaede, P; Jensen, GV; Larsen, N; Parving, HH; Pedersen, O; Vedel, P	1
Siegel-Axel, DI	1
Cassis, LA; Daugherty, A; Manning, MW	1
Blumenstein, M; Dietrich, W	1
Mehta, JL; Singh, BM	1
Mohanram, A; Toto, RD	1
Gaede, PH; Jensen, GV; Jepsen, PV; Larsen, JN; Parving, HH; Pedersen, OB	1
Cassis, LA; Daugherty, A	1
Remuzzi, G; Schieppati, A	1
Jabs, K; Kon, V	1
Cassis, L; Daugherty, A	1
Thomas, WG	1
Cheng, Z; Liu, J; Lü, J	1
Howes, JB; Howes, LG; Lowy, A; Tran, D	1
Cassis, LA; Daugherty, A; Dellsperger, KC; Gavrila, D; Li, WG; McCormick, ML; Miller, FJ; Oberley, LW; Thomas, M; Weintraub, NL	1
Ito, T; Katano, Y; Kubota, I; Shishido, T; Takasaki, S; Takeishi, Y; Tasaki, K; Tomoike, H; Wakabayashi, I	1
Ayabe, N; Babaev, VR; Fazio, S; Fogo, AB; Ichikawa, I; Kon, V; Linton, MF; Tang, Y; Tanizawa, T	1
Brooks, LG; D'Angola, A; Gonzales, JA; McCabe, PM; Mendez, AJ; Nation, DA; Paredes, J; Schneiderman, N; Szeto, A; Zaias, J	1
FitzGerald, GA; Lawson, JA; Lee, E; Puré, E; Rader, DJ; Ricciotti, E; Song, W; Wang, M	1
Bonomini, V; Feletti, C; Scolari, MP; Stefoni, S; Vangelista, A	1
Finta, KM; Fischer, MJ; Gordon, D; Lee, L; Pitt, B; Webb, RC	1
Abe, S; Kinukawa, N; Nakamura, M	1
Lee, AF; Struthers, AD	1
Chen, HJ; Li, DY; Mehta, JL; Phillips, MI; Saldeen, T	1
Ambrosioni, E; Bacchelli, S; Borghi, C; Degli Esposti, D	1
Selchau, M	1
Freyss-Beguin, M; Mathieu-Levy, N; van Brussel, E	1
Bunce, I; Knowles, BR; Richardson, ER; Whitaker, AN	1

Reviews

11 review(s) available for angiotensin ii and Hyperlipemia

Article	Year
Angiotensin II, Hypercholesterolemia, and Vascular Smooth Muscle Cells: A Perfect Trio for Vascular Pathology. International journal of molecular sciences, 2020, Jun-25, Volume: 21, Issue:12 Topics: Angiotensin II; Animals; Antihypertensive Agents; Atherosclerosis; Blood Pressure; Cardiovascular Diseases; Cells, Cultured; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Signal Transduction	2020
Cerivastatin: a cellular and molecular drug for the future? Cellular and molecular life sciences : CMLS, 2003, Volume: 60, Issue:1 Topics: Angiotensin II; Animals; Anticholesteremic Agents; Arteriosclerosis; Endothelium, Vascular; Epoprostenol; Extracellular Matrix; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Monocytes; Muscle, Smooth, Vascular; Neovascularization, Physiologic; Pyridines; Receptors, Angiotensin; Thrombosis	2003
Interactions between the renin-angiotensin system and dyslipidemia: relevance in the therapy of hypertension and coronary heart disease. Archives of internal medicine, 2003, Jun-09, Volume: 163, Issue:11 Topics: Angiotensin II; Animals; Cholesterol; Coronary Artery Disease; Endothelium, Vascular; Humans; Hyperlipidemias; Hypertension; Lipoproteins, LDL; Oxidation-Reduction; Reactive Oxygen Species; Renin-Angiotensin System	2003
Outcome studies in diabetic nephropathy. Seminars in nephrology, 2003, Volume: 23, Issue:3 Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hyperglycemia; Hyperlipidemias; Hypertension, Renal; Irbesartan; Kidney Failure, Chronic; Male; Outcome Assessment, Health Care; Proteinuria; Renin-Angiotensin System; Risk Factors; Smoking; Tetrazoles	2003
Mouse models of abdominal aortic aneurysms. Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:3 Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Calcium Chloride; Cholesterol; Disease Models, Animal; Extracellular Matrix Proteins; Female; Genetic Engineering; Genetic Predisposition to Disease; Humans; Hyperlipidemias; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Knockout; Mice, Mutant Strains; Models, Animal; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pancreatic Elastase; Protease Inhibitors; Receptors, LDL; Renin; Species Specificity	2004
Proteinuria and its consequences in renal disease. Acta paediatrica (Oslo, Norway : 1992). Supplement, 2003, Volume: 92, Issue:443 Topics: Angiotensin II; Chronic Disease; Disease Progression; Fabry Disease; Humans; Hyperlipidemias; Hypertension, Renal; Hypertrophy; Kidney Diseases; Kidney Glomerulus; Proteinuria	2003
Angiotensin in atherosclerosis. Current opinion in nephrology and hypertension, 2004, Volume: 13, Issue:3 Topics: Angiotensin II; Arteriosclerosis; Diabetes Mellitus; Disease Progression; Estrogens; Humans; Hyperlipidemias; Hypertension; Inflammation; Insulin Resistance; Risk Factors	2004
Angiotensin II-mediated development of vascular diseases. Trends in cardiovascular medicine, 2004, Volume: 14, Issue:3 Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Arteriosclerosis; Blood Pressure; Disease Models, Animal; Endothelium, Vascular; Humans; Hyperlipidemias; Macrophages; Vascular Diseases	2004
The impact of angiotensin converting enzyme inhibitors on the arterial wall. Vascular medicine (London, England), 1996, Volume: 1, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Endothelium, Vascular; Humans; Hyperlipidemias; Hypertension; Sympathetic Nervous System; Vascular Diseases	1996
ACE-inhibitors and atherosclerosis. European journal of epidemiology, 1992, Volume: 8 Suppl 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Diseases; Arteriosclerosis; Captopril; Cilazapril; Disease Models, Animal; Haplorhini; Hyperlipidemias; Lipid Metabolism; Peptidyl-Dipeptidase A; Pyridazines; Rabbits; Rats	1992
[Angiotics. 48. I. Hypertensive agents. II. Hypotensive agents. 3. Vasodilator agents. IV. Agents for the treatment of lipid metabolism disorders]. Pharmazeutische Praxis, 1970, Volume: 9 Topics: Acetylcholine; Adenosine Triphosphate; Amines; Angiotensin II; Anticholesteremic Agents; Antihypertensive Agents; Diazoxide; Ergot Alkaloids; Humans; Hyperlipidemias; Kallikreins; Lipid Mobilization; Methyldopa; Nicotinic Acids; Parasympatholytics; Pargyline; Phenethylamines; Phytotherapy; Plants, Medicinal; Propylamines; Protoveratrines; Purines; Rauwolfia; Sympatholytics; Sympathomimetics; Tissue Extracts; Vasodilator Agents	1970

Trials

3 trial(s) available for angiotensin ii and Hyperlipemia

Article	Year
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. The New England journal of medicine, 2003, Jan-30, Volume: 348, Issue:5 Topics: Amputation, Surgical; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Exercise; Female; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Obesity; Risk Factors; Smoking Cessation; Stroke; Vitamins	2003
[The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes]. Ugeskrift for laeger, 2003, Jun-23, Volume: 165, Issue:26 Topics: Amputation, Surgical; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Exercise; Female; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Obesity; Risk Factors; Smoking Cessation; Stroke; Vitamins	2003
Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men. Diabetes, obesity & metabolism, 2005, Volume: 7, Issue:3 Topics: Acetylcholine; Aged; Analysis of Variance; Angiotensin II; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Forearm; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Infusions, Intravenous; Male; Middle Aged; Nitric Oxide Synthase; Nitroprusside; Norepinephrine; omega-N-Methylarginine; Pyridines; Vascular Resistance; Vasodilator Agents	2005

Other Studies

25 other study(ies) available for angiotensin ii and Hyperlipemia

Article	Year
Metabolomic Profiling of Angiotensin-II-Induced Abdominal Aortic Aneurysm in Ldlr International journal of molecular sciences, 2022, Jun-07, Volume: 23, Issue:12 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Disease Models, Animal; Energy Metabolism; Glutamine; Glycine; Hypercholesterolemia; Hyperlipidemias; Lipids; Metabolomics; Mice; Mice, Inbred C57BL; Nitric Oxide; Receptors, LDL	2022
Hyperlipidemia inhibits the protective effect of lisinopril after myocardial infarction via activation of dendritic cells. Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:7 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Apolipoproteins E; Dendritic Cells; Disease Models, Animal; Heart; Humans; Hyperlipidemias; Lipoproteins, LDL; Lisinopril; Mice; Mice, Knockout; Myeloid Differentiation Factor 88; Myocardial Infarction; Myocardium; NF-kappa B; Signal Transduction; Toll-Like Receptor 4; Ventricular Remodeling	2020
Bmal1 Deletion in Myeloid Cells Attenuates Atherosclerotic Lesion Development and Restrains Abdominal Aortic Aneurysm Formation in Hyperlipidemic Mice. Arteriosclerosis, thrombosis, and vascular biology, 2020, Volume: 40, Issue:6 Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; ARNTL Transcription Factors; Atherosclerosis; Cells, Cultured; Crosses, Genetic; Diet, High-Fat; Gene Deletion; Gene Expression; Hyperlipidemias; Inflammation; Integrases; Macrophages, Peritoneal; Mice; Mice, Knockout; Muramidase; Myeloid Cells; Promoter Regions, Genetic; Receptors, LDL	2020
A Dual Role of Heme Oxygenase-1 in Angiotensin II-Induced Abdominal Aortic Aneurysm in the Normolipidemic Mice. Cells, 2021, 01-15, Volume: 10, Issue:1 Topics: Aneurysm; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Cardiovascular Diseases; Cell Line; Collagen; Genotype; Heme Oxygenase-1; Humans; Hyperlipidemias; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Myocytes, Smooth Muscle; Oxidative Stress; Plasminogen Activator Inhibitor 1; Receptor, Angiotensin, Type 2; Serpin E2; Skin; Swine; Tissue Inhibitor of Metalloproteinase-2	2021
Use of a Fluorescent Substrate to Measure ACE2 Activity in the Mouse Abdominal Aorta. Methods in molecular biology (Clifton, N.J.), 2017, Volume: 1614 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aorta, Abdominal; Disease Models, Animal; Fluorescent Antibody Technique; Fluorescent Dyes; Hyperlipidemias; Mice; Mice, Knockout; Peptidyl-Dipeptidase A; Receptors, LDL; Sodium Chloride; Vasoconstrictor Agents	2017
Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) induces anti-hyperlipidemia leading to reduction of angiotensin II-induced aneurysm development. PloS one, 2017, Volume: 12, Issue:8 Topics: Angiotensin II; Animals; Aortic Aneurysm; Atherosclerosis; Disease Models, Animal; Heparin-binding EGF-like Growth Factor; Hyperlipidemias; Liver; Male; Mice; Receptors, LDL	2017
[Protective effect of acupuncture on heart in mice with hyperlipemia and its mechanism]. Zhongguo zhen jiu = Chinese acupuncture & moxibustion, 2014, Volume: 34, Issue:4 Topics: Acupuncture Points; Acupuncture Therapy; Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Heart; Heart Diseases; Humans; Hyperlipidemias; Male; Mice; Mice, Inbred C57BL; Myocardium	2014
Understanding abdominal aortic aneurysm. The New England journal of medicine, 2009, Sep-10, Volume: 361, Issue:11 Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Cyclophilin A; Humans; Hyperlipidemias; Inflammation; Matrix Metalloproteinase 2; Mice; Mice, Knockout; Oxidative Stress; Reactive Oxygen Species	2009
Prostacyclin receptor suppresses cardiac fibrosis: role of CREB phosphorylation. Journal of molecular and cellular cardiology, 2010, Volume: 49, Issue:2 Topics: Angiotensin II; Animals; Cell Separation; Collagen; Cyclic AMP Response Element-Binding Protein; Down-Regulation; E1A-Associated p300 Protein; Epoprostenol; Fibroblasts; Fibrosis; Hyperlipidemias; Mice; Mice, Knockout; Models, Biological; Myocardium; NADPH Oxidases; Phosphorylation; Receptors, Epoprostenol; Signal Transduction; Transforming Growth Factor beta	2010
Deletion of EP4 on bone marrow-derived cells enhances inflammation and angiotensin II-induced abdominal aortic aneurysm formation. Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:2 Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Bone Marrow Cells; Bone Marrow Transplantation; Chemokine CCL2; Elastin; Female; Gene Deletion; Hyperlipidemias; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Animal; Receptors, LDL; Receptors, Prostaglandin E, EP4 Subtype; Risk Factors	2011
Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arteriosclerosis, thrombosis, and vascular biology, 2003, Mar-01, Volume: 23, Issue:3 Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Arteriosclerosis; Cholesterol; Doxycycline; Hyperlipidemias; Lipoproteins; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Mutant Strains	2003
[Microalbuminuria as a warning sign of diabetic nephropathy. Test your diabetics early!]. MMW Fortschritte der Medizin, 2003, Mar-06, Volume: 145, Issue:10 Topics: Adolescent; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Kidney Failure, Chronic; Risk Factors; Smoking Cessation; Sodium Chloride Symporter Inhibitors; Time Factors	2003
Double trouble for type 1 angiotensin receptors in atherosclerosis. The New England journal of medicine, 2005, Feb-03, Volume: 352, Issue:5 Topics: Angiotensin II; Animals; Arteriosclerosis; Dimerization; Factor XIIIa; Humans; Hyperlipidemias; Hypertension; Mice; Monocytes; Receptor, Angiotensin, Type 1; Transglutaminases	2005
[Effects of Peritrophe roxburghiana on blood pressure in renal hypertensive and hyperlipidemic rats]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2004, Volume: 27, Issue:12 Topics: Acanthaceae; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Drugs, Chinese Herbal; Hyperlipidemias; Hypertension, Renovascular; Male; Nitric Oxide; Plants, Medicinal; Rats; Rats, Sprague-Dawley	2004
Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:8 Topics: Angiotensin II; Animals; Antioxidants; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Apolipoproteins E; Blood Pressure; Dinoprost; Hyperlipidemias; Lipids; Macrophages; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Mutant Strains; Osteopontin; Oxidative Stress; Sialoglycoproteins; Vasoconstrictor Agents; Vitamin E	2005
Diminution of angiotensin II-induced contraction of the abdominal aorta isolated from Watanabe heritable hyperlipidemic rabbits. Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 2005, Volume: 41, Issue:2 Topics: Angiotensin II; Animals; Aorta, Abdominal; Arteriosclerosis; Body Weight; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Hyperlipidemias; Imidazoles; In Vitro Techniques; Lipids; Male; Nitroarginine; Pyridines; Rabbits; Vasoconstriction; Vasoconstrictor Agents	2005
Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice. Atherosclerosis, 2006, Volume: 184, Issue:2 Topics: Angiotensin II; Animals; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Apolipoproteins E; Atherosclerosis; Chemokine CCL2; Disease Models, Animal; Female; Follow-Up Studies; Hyperlipidemias; Immunohistochemistry; Infusions, Intravenous; Mice; Mice, Inbred C57BL; Receptors, CCR2; Receptors, Chemokine; RNA	2006
The effect of social environment on markers of vascular oxidative stress and inflammation in the Watanabe heritable hyperlipidemic rabbit. Psychosomatic medicine, 2008, Volume: 70, Issue:3 Topics: Agonistic Behavior; Angiotensin II; Animals; Aorta, Thoracic; Arousal; Atherosclerosis; C-Reactive Protein; Cholesterol; Epinephrine; Hyperlipidemias; Inflammation Mediators; Lipoproteins, HDL; Lipoproteins, LDL; Male; NADPH Oxidases; Norepinephrine; Oxidative Stress; Peptidyl-Dipeptidase A; Rabbits; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Social Environment; Social Isolation; Stress, Psychological	2008
Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation. Circulation, 2008, Mar-11, Volume: 117, Issue:10 Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Hyperlipidemias; Intramolecular Oxidoreductases; Male; Mice; Mice, Knockout; Oxidative Stress; Prostaglandin-E Synthases; Prostaglandins; Receptors, LDL; Up-Regulation	2008
Atherosclerosis in uremia: a longitudinal study. The American journal of clinical nutrition, 1980, Volume: 33, Issue:7 Topics: Angiotensin II; Arteriosclerosis; Blood Pressure; Cholesterol; Chronic Disease; Humans; Hyperlipidemias; Kidney Transplantation; Lipoproteins; Renal Dialysis; Transplantation, Homologous; Triglycerides; Uremia	1980
Ramipril prevents impaired endothelium-dependent relaxation in arteries from rabbits fed an atherogenic diet. Atherosclerosis, 1993, Volume: 100, Issue:2 Topics: Acetylcholine; Angiotensin II; Animals; Aorta, Thoracic; Cholesterol; Diet, Atherogenic; Dose-Response Relationship, Drug; Endothelium, Vascular; Hyperlipidemias; In Vitro Techniques; Male; Nitroglycerin; Phenylephrine; Rabbits; Ramipril; Vasodilation	1993
Aortic medial necrosis with or without thrombosis in rabbits treated with Russell's viper venom and angiotensin II. Atherosclerosis, 1997, Feb-10, Volume: 128, Issue:2 Topics: Angiotensin II; Animals; Aorta; Aortic Diseases; Blood Pressure; Daboia; Drug Synergism; Female; Hyperlipidemias; Male; Myocardial Infarction; Necrosis; Rabbits; Reference Values; Serotonin; Thrombosis; Tunica Media; Viper Venoms	1997
Attenuation of tissue P-selectin and MCP-1 expression and intimal proliferation by AT(1) receptor blockade in hyperlipidemic rabbits. Biochemical and biophysical research communications, 2001, Mar-30, Volume: 282, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Arteriosclerosis; Chemokine CCL2; Diet, Atherogenic; Hyperlipidemias; Losartan; Male; P-Selectin; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2	2001
[Pharmacologic study of 4 fractions of Soja lipexidase]. Archives internationales de pharmacodynamie et de therapie, 1971, Volume: 193, Issue:2 Topics: Angiotensin II; Animals; Drug Antagonism; Glycine max; Hypercholesterolemia; Hyperlipidemias; Hypothermia; Hypoxia; Male; Oxygenases; Plants, Edible; Rats; Surface-Active Agents; Trypsin Inhibitors	1971
Hyperlipidemia in experimental disseminated intravascular coagulation. The Journal of trauma, 1974, Volume: 14, Issue:2 Topics: Aminocaproates; Analysis of Variance; Angiotensin II; Animals; Cholesterol; Disseminated Intravascular Coagulation; Epinephrine; Fatty Acids, Nonesterified; Female; Hemolysis; Hyperlipidemias; Kidney Cortex Necrosis; Kidney Glomerulus; Lactates; Lipoproteins, VLDL; Liver; Male; Phenoxybenzamine; Propranolol; Rabbits; Thrombin; Thrombosis; Triglycerides	1974